Home » USA Broker Ratings » Safeguard Scientifics New – Consensus Indicates Potential 162.3% Upside

Safeguard Scientifics New – Consensus Indicates Potential 162.3% Upside

Safeguard Scientifics New found using ticker (SFE) now have 1 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price ranges between 16 and 16 with the average target price sitting at 16. Given that the stocks previous close was at 6.1 this would indicate that there is a potential upside of 162.3%. The 50 day MA is 6.14 and the 200 day moving average is 6.77. The market cap for the company is $127m. Find out more information at: http://www.safeguard.com

Safeguard Scientifics no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Safeguard Scientifics in 1981. Safeguard Scientifics is based in Radnor, Pennsylvania with additional office in Weston, Massachusetts.

Join us on our new LinkedIn page

Follow us on LinkedIn